SCHEMBL657848

SCHEMBL657848

O=C(O)CC(CC(=O)OC(=O)CC(CC(=O)O)c1cccs1)c1cccs1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
KEAP1 Q14145 1/20 0.39
GABBR2 O75899 2/20 0.39
GABBR1 Q9UBS5 2/20 0.39
CYP2C19 P33261 1/20 0.38
HPGD P15428 2/20 0.37
NPC1 O15118 2/20 0.37
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658090 0.90 CES2 (0.46) CES2CES1KEAP1GABBR2GABBR1
SCHEMBL341042 0.80 GABBR2 (0.56) CES2CES1KEAP1GABBR2GABBR1
SCHEMBL27878861 0.80 ALOX5 (0.41) CES2CES1KEAP1GABBR2GABBR1
SCHEMBL22775864 0.80 CES2 (0.41) CES2CES1KEAP1GABBR2GABBR1
SCHEMBL7277764 0.77 MIF (0.53) CES2CES1KEAP1GABBR2GABBR1
SCHEMBL11051137 0.77 CYSLTR2 (0.43) HPGDTSHRFFAR1
SCHEMBL4446826 0.74 CES2 (0.49) CES2CES1KEAP1CYP2C19HPGD
SCHEMBL657290 0.74 GABBR2 (0.61) GABBR2GABBR1ALDH1A1MEN1KMT2A
SCHEMBL3962690 0.74 CES2 (0.49) CES2CES1KEAP1CYP2C19HPGD
SCHEMBL4364840 0.74 ALDH1A1 (0.49) CES2CES1KEAP1CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB CES2 4847/4885CES1 4125/4885KEAP1 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.